Abdominal migraine

Last updated
Abdominal migraine
Specialty Neurology
Symptoms episodes of abdominal pain
Usual onsetvariable
Causesmigraine triggers
Risk factors cyclic vomiting syndrome, PTSD, functional gastrointestinal disorder
Diagnostic method symptoms
Differential diagnosis irritable bowel syndrome, peptic ulcer disease, gastroesophageal reflux disease, mast cell activation syndrome, celiac artery compression syndrome
Preventionavoiding triggers (different for each patient)
Treatmenta range of experimental medications, including TCAs and anticonvulsants
Prognosis good in pediatrics, variable in adults
Frequencybetween 1% and 9% of children
Deathspoorly studied

Abdominal migraine(AM) is a functional disorder that usually manifests in childhood and adolescence, without a clear pathologic mechanism or biochemical irregularity. Children frequently experience sporadic episodes of excruciating central abdominal pain accompanied by migrainous symptoms like nausea, vomiting, severe headaches, and general pallor. [1] Abdominal migraine can be diagnosed based on clinical criteria and the exclusion of other disorders. [2]

Contents

The US Food and Drug Administration has not approved any drugs for the treatment of abdominal migraine. The goal of treatment is usually to prevent attacks, and this is often achieved through nonpharmacologic intervention. [3]

Research has indicated that the incidence of abdominal migraine in children falls within the range of 0.4% [4] to 4%. [2] The condition primarily affects children aged 3 to 10 years, with a higher prevalence in females. [5]

Signs and Symptoms

Midline abdominal pain with paroxysmal, recurrent, acute onset attacks that last an average of 17 hours are the hallmarks of abdominal migraine. [6] There have been reports that these attacks can last anywhere from two to seventy-two hours. [5] Although it has also been reported to be diffuse and colicky, the pain is usually described as dull and periumbilical. 91% of patients have anorexia, 73% to 91% have nausea, 35% to 50% vomit, and 93% to 100% of patients have associated pallor. [7] The attack usually comes to an abrupt end. [5] The average annual frequency of abdominal migraine attacks in patients is 14. [6]

Although nonspecific prodromes can occur before attacks, abdominal migraine attacks are usually sporadic. This can include behavioral and mood swings, anorexia, flushing, diarrhea, and auras that include numbness, slurred speech, tingling in the distal extremities, and flashing lights. [5] Weeks to months may pass between episodes, and during this time patients usually experience no symptoms. [8]

Causes

Abdominal migraine has been linked to specific alterations in the gut-brain axis, vascular dysregulation, modifications in the central nervous system, and genetic factors. [9]

Risk factors

Abdominal migraine pathophysiology may involve psychological factors. Abuse and stressful events are two risk factors for recurrent abdominal pain, for instance. Furthermore, it has been demonstrated that kids with functional gastrointestinal disorders experience mental health conditions like anxiety and depression more frequently than kids without these conditions. [10]

Triggers

There are several typical causes of attacks of abdominal migraines. Stressors related to work and family life, irregular sleep patterns, extended fasts and food deprivation, dehydration, exercise, travel, high-amine foods, foods containing flavoring, coloring, and monosodium glutamate (MSG), and flashing lights are a few common triggers. [5] [8]

Genetics

A significant hereditary component may be involved in abdominal and other migraines due to their strong familial incidence, [11] especially in the case of mutations affecting cell membrane transport (channelopathies). [12] [13]

Mechanism

While the pathophysiology of functional gastrointestinal disorders (FGIDs) has many potential contributors, the etiology of abdominal migraine is still unknown. [14]

It is thought that abnormal electrical discharge from the hypothalamus that travels to the cortex and autonomic nervous system [15] or variations in the cerebral artery's blood flow velocity cause attacks. [16] In patients with FGIDs, there appears to be a disruption in the complex brain-gut axis. [17] Many episodic functional gastrointestinal disorders in childhood have been linked to mitochondrial disease, [18] hypothalamic-pituitary-axis dysfunction, and gene mutations; these associations have not, however, been studied in patients diagnosed with abdominal migraine. [19]

Diagnosis

It's critical to rule out organic diseases as the source of a child's symptoms while also taking the patient's functional state into account. When diagnosing abdominal migraine, a patient's complete medical history and physical examination are crucial. Additionally, any potential alarm signs and symptoms should be carefully examined. The presence of visible or occult blood in the stool, dysphagia, hematemesis, bilious vomiting, fever, changes in growth pattern, and weight loss are a few examples of alarm symptoms. [20] Further imaging and testing should be carried out if these alarm signs or symptoms are apparent. [21]

The Rome IV criteria state that paroxysmal bouts of intense, acute periumbilical, midline, or diffuse abdominal pain lasting at least an hour, exhibiting a recurrent pattern, being incapacitating, and interfering with regular activities can be used to diagnose abdominal migraine if at least two of these episodes take place over a six-month period. There should be weeks or months without any symptoms in between attacks. The following symptoms must be present in at least two instances: pallor, photophobia, headache, nausea, vomiting, and anorexia. Lastly, there is no other medical diagnosis that can account for the symptoms. [22]

Abdominal migraine is defined by the International Classification of Headache Disorders III criteria as five or more episodes of abdominal pain lasting two to seventy-two hours. A minimum of two out of three of the following criteria must also be met by the pain: dull or "just sore" quality; midline location, periumbilical, or poorly localized; and moderate to severe intensity. Pallor, nausea, vomiting, and anorexia are associated symptoms that the patient should have at least two of. [7]

Differential diagnosis

Abdominal migraine must be distinguished from other causes of chronic or recurrent abdominal pain. These include irritable bowel syndrome, peptic ulcer disease, and gastroesophageal reflux disease. [3] It must also be distinguished from causes of acute abdominal pain, such as appendicitis, as wrong diagnosis may lead to unnecessary appendectomy. [23]

Treatment

Because there are so few studies in the literature, there are no firm recommendations for the treatment of abdominal migraines. [24] The majority of treatment options are predicated on anecdotal evidence, a small number of studies conducted on a relatively small number of children, and a close correlation between abdominal migraines and both migraine headaches and FGIDs. [25]

When treating patients with abdominal migraines, doctors may find the STRESS mnemonic useful. It stands for stress management, travel advice, rest, emergency symptoms, sparkling lights, and snacks to avoid. [26]

Certain triggers, like bright light, restless nights, travel, and extended fasting, should probably be minimized or avoided once they have been identified. [19] Emotional stressors from family or school activities can be a trigger for certain kids, so it's best to minimize or stay away from them. [3] Although there are no particular randomized trials evaluating the efficacy of biofeedback and counselling in treating abdominal migraines, it is believed that these interventions may be helpful if emotional stress is a trigger factor in the development of migraine in children. [27]

It's unclear what function elimination diets serve. Nonetheless, in patients experiencing both migraine and IBS symptoms, an immunoglobulin G (IgG)-based elimination diet shows promise in lowering migraine episodes. [28] There isn't much more proof that a child's diet has a significant impact on when migraines begin. [29]

In one study, 14 children with abdominal migraine were administered pizotifen syrup, a serotonin and histamine antagonist. After four months, 70% of the patients said their symptoms had improved. Their symptoms were noticeably milder and less frequent. [30] Propranolol and cyproheptadine syrup were found to alleviate symptoms in a retrospective review. [25] Flunarizine use was found to reduce the frequency and duration of abdominal migraine attacks in another retrospective review. [31]

Analgesics, triptans, and antiemetics may be helpful for sudden attacks of abdominal migraines. It has been suggested that patients with nausea, vomiting, or anorexia might benefit more from nasal sprays or suppositories. [5] Acute attacks have been reported to be resolved by acetaminophen and ibuprofen. [32] Intranasal sumatriptan alleviated the symptoms of abdominal migraine in two children, according to a case report. [33] In refractory cases, intravenous sodium valproate has been reported to resolve abdominal migraine episodes. [34] According to a case series, intravenous dihydroergotamine treatment prevented abdominal migraine attacks in five out of six pediatric patients. [35]

Prognosis

Abdominal migraine can have a significant impact on day-to-day life. [36] Children may miss school or other activities. [36] It resolves in many patients. [23] [37]

Epidemiology

Abdominal migraine primarily affects children, for whom it is a common cause of chronic abdominal pain. It may be as high as 9% or as low as 1% among children. [23] It is rare in adults. [3] However, children diagnosed with abdominal migraines may have migraine headaches as adults. [38] The mean age of diagnosis is 7 years. [39] [40] It appears to be slightly more common in women. [23]

History

This condition was first described in 1921 by Buchanan. [41] It was once considered a controversial diagnosis. [42] However, it is now accepted as a common cause of chronic abdominal pain in children. [43]

See also

Related Research Articles

<span class="mw-page-title-main">Migraine</span> Disorder resulting in recurrent moderate-severe headaches

Migraine is a genetically influenced complex neurological disorder characterized by episodes of moderate-to-severe headache, most often unilateral and generally associated with nausea and light and sound sensitivity. Other characterizing symptoms may include vomiting, cognitive dysfunction, allodynia, and dizziness. Exacerbation of headache symptoms during physical activity is another distinguishing feature. Up to one-third of migraine sufferers experience aura, a premonitory period of sensory disturbance widely accepted to be caused by cortical spreading depression at the onset of a migraine attack. Although primarily considered to be a headache disorder, migraine is highly heterogenous in its clinical presentation and is better thought of as a spectrum disease rather than a distinct clinical entity. Disease burden can range from episodic discrete attacks to chronic disease.

<span class="mw-page-title-main">Headache</span> Pain in the head, neck, or face

Headache, also known as cephalalgia, is the symptom of pain in the face, head, or neck. It can occur as a migraine, tension-type headache, or cluster headache. There is an increased risk of depression in those with severe headaches.

A medication overuse headache (MOH), also known as a rebound headache, usually occurs when painkillers are taken frequently to relieve headaches. These cases are often referred to as painkiller headaches. Rebound headaches frequently occur daily, can be very painful and are a common cause of chronic daily headache. They typically occur in patients with an underlying headache disorder such as migraine or tension-type headache that "transforms" over time from an episodic condition to chronic daily headache due to excessive intake of acute headache relief medications. MOH is a serious, disabling and well-characterized disorder, which represents a worldwide problem and is now considered the third-most prevalent type of headache. The proportion of patients in the population with Chronic Daily Headache (CDH) who overuse acute medications ranges from 18% to 33%. The prevalence of medication overuse headache (MOH) varies depending on the population studied and diagnostic criteria used. However, it is estimated that MOH affects approximately 1-2% of the general population, but its relative frequency is much higher in secondary and tertiary care.

Functional gastrointestinal disorders (FGID), also known as disorders of gut–brain interaction, include a number of separate idiopathic disorders which affect different parts of the gastrointestinal tract and involve visceral hypersensitivity and motility disturbances.

Cyclic vomiting syndrome (CVS) is a chronic functional condition of unknown pathogenesis. CVS is characterized as recurring episodes lasting a single day to multiple weeks. Each episode is divided into four phases: inter-episodic, prodrome, vomiting, and recovery. Inter-episodic phase, is characterized as no discernible symptoms, normal everyday activities can occur, and this phase typically lasts one week to one month. The prodrome phase is known as the pre-emetic phase, characterized by the initial feeling of an approaching episode, still able to keep down oral medication. Emetic or vomiting phase is characterized as intense persistent nausea, and repeated vomiting typically lasting hours to days. Recovery phase is typically the phase where vomiting ceases, nausea diminishes or is absent, and appetite returns. "Cyclic vomiting syndrome (CVS) is a rare abnormality of the neuroendocrine system that affects 2% of children." This disorder is thought to be closely related to migraines and family history of migraines.

Intestinal malrotation is a congenital anomaly of rotation of the midgut. It occurs during the first trimester as the fetal gut undergoes a complex series of growth and development. Malrotation can lead to a dangerous complication called volvulus, in which cases emergency surgery is indicated. Malrotation can refer to a spectrum of abnormal intestinal positioning, often including:

Chronic paroxysmal hemicrania (CPH) is a severe debilitating unilateral headache usually affecting the area around the eye. It normally consists of multiple severe, yet short, headache attacks affecting only one side of the cranium. Retrospective surveys indicated that paroxysmal hemicrania was more common in women. However, subsequent prospective research showed an equal prevalence between females and males, with a ratio close to 1:1. Unlike in migraine, it has no neurological symptoms associated with it. CPH headaches are treated through the use of non-steroidal anti-inflammatory drugs, with indomethacin found to be especially effective in eliminating symptoms.

<span class="mw-page-title-main">Aura (symptom)</span> Symptom of epilepsy and migraine

An aura is a perceptual disturbance experienced by some with epilepsy or migraine. An epileptic aura is actually a minor seizure.

<span class="mw-page-title-main">Intestinal pseudo-obstruction</span> Medical condition

Intestinal pseudo-obstruction (IPO) is a clinical syndrome caused by severe impairment in the ability of the intestines to push food through. It is characterized by the signs and symptoms of intestinal obstruction without any lesion in the intestinal lumen. Clinical features mimic those seen with mechanical intestinal obstructions and can include abdominal pain, nausea, abdominal distension, vomiting, dysphagia and constipation depending upon the part of the gastrointestinal tract involved.

Abdominal epilepsy is a rare condition most frequently found in children, consisting of gastrointestinal disturbances caused by epileptiform seizure activity. Though a few cases of it have been reported in adults too. It has been described as a type of temporal lobe epilepsy. Responsiveness to anticonvulsants can aid in the diagnosis. Distinguishing features of abdominal epilepsy include (1) Abnormal laboratory, radiographic, and endoscopic findings revealing paroxysmal GI manifestations of unknown origin (2) CNS symptoms (3) Abnormal EEG. Most published medical literature dealing with abdominal epilepsy is in the form of individual case reports. A 2005 review article found a total of 36 cases described in the medical literature.

<span class="mw-page-title-main">Mitochondrial neurogastrointestinal encephalopathy syndrome</span> Medical condition

Mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE) is a rare autosomal recessive mitochondrial disease. It has been previously referred to as polyneuropathy, ophthalmoplegia, leukoencephalopathy, and intestinal pseudoobstruction. The disease presents in childhood, but often goes unnoticed for decades. Unlike typical mitochondrial diseases caused by mitochondrial DNA (mtDNA) mutations, MNGIE is caused by mutations in the TYMP gene, which encodes the enzyme thymidine phosphorylase. Mutations in this gene result in impaired mitochondrial function, leading to intestinal symptoms as well as neuro-ophthalmologic abnormalities. A secondary form of MNGIE, called MNGIE without leukoencephalopathy, can be caused by mutations in the POLG gene.

<span class="mw-page-title-main">Antimigraine drug</span> Medication intended to reduce the effects or intensity of migraine headache

Antimigraine drugs are medications intended to reduce the effects or intensity of migraine headache. They include drugs for the treatment of acute migraine symptoms as well as drugs for the prevention of migraine attacks.

New daily persistent headache (NDPH) is a primary headache syndrome which can mimic chronic migraine and chronic tension-type headache. The headache is daily and unremitting from very soon after onset, usually in a person who does not have a history of a primary headache disorder. The pain can be intermittent, but lasts more than 3 months. Headache onset is abrupt and people often remember the date, circumstance and, occasionally, the time of headache onset. One retrospective study stated that over 80% of patients could state the exact date their headache began.

Vestibular migraine (VM) is vertigo with migraine, either as a symptom of migraine or as a related neurological disorder.

The classification of all headaches, including migraines, is organized by the International Headache Society, and published in the International Classification of Headache Disorders (ICHD). The current version, the ICHD-3 beta, was published in 2013.

Preventive treatment of migraine can be an important component of migraine management. The goals of preventive therapy are to reduce the frequency, painfulness, and/or duration of migraine attacks, and to increase the effectiveness of abortive therapy. Another reason to pursue prevention is to avoid medication overuse headache (MOH), otherwise known as rebound headache, which can arise from overuse of pain medications, and can result in chronic daily headache. Preventive treatments of migraine include medications, nutritional supplements, lifestyle alterations, and surgery. Prevention is recommended in those who have headaches more than two days a week, cannot tolerate the medications used to treat acute attacks, or those with severe attacks that are not easily controlled.

Abdominal aura, also known as visceral aura and epigastric aura, is a type of somatosensory aura that typically manifests as abdominal discomfort in the form of nausea, malaise, hunger, or pain. Abdominal aura is typically associated with epilepsy, especially temporal lobe epilepsy, and it can also be used in the context of migraine. The term is used to distinguish it from other types of somatosensory aura, notably visual disturbances and paraesthesia. The abdominal aura can be classified as a somatic hallucination. Pathophysiologically, the abdominal aura is associated with aberrant neuronal discharges in sensory cortical areas representing the abdominal viscera.

Migraine may be treated either prophylactically (preventive) or abortively (rescue) for acute attacks. Migraine is an complex condition; there are various preventive treatments which disrupt different links in the chain of events that occur during a migraine attack. Rescue treatments also target and disrupt different processes occurring during migraine.

Neck-tongue syndrome (NTS), which was first recorded in 1980, is a rare disorder characterized by neck pain with or without tingling and numbness of the tongue on the same side as the neck pain. Sharp lateral movement of the head triggers the pain, usually lasting from a few seconds to a few minutes. Headaches may occur with the onset of NTS. The typical age of onset is around adolescence and may occur as early as 8–15 years old. However, it is worth noting that clinical onset can occur earlier or later and NTS onset related to trauma can occur at any age, beginning after the incident.

<span class="mw-page-title-main">Recurrent painful ophthalmoplegic neuropathy</span> Medical condition

Recurrent painful ophthalmoplegic neuropathy (RPON), previously known as ophthalmoplegic migraine (OM), is a rare neurological disorder that is characterized by repeated headache attacks and reversible ipsilateral paresis of one or more ocular cranial nerves (CN). Oculomotor nerve (CNIII) is by far the most common cranial nerve involves in RPON, while abducens nerve (CNVI) and trochlear nerve (CNIV) involvements are also reported. Globally, RPON was estimated to have an annual incidence rate of 0.7 per million as of 1990, no further epidemiological studies have been conducted. It occurs more often in children and females.

References

  1. ↑ Angus-Leppan, Heather; Saatci, Defne; Sutcliffe, Alastair; Guiloff, Roberto J (February 19, 2018). "Abdominal migraine". BMJ. 360: k179. doi: 10.1136/bmj.k179 . ISSN   0959-8138. PMID   29459383.
  2. 1 2 Carson, Laura; Lewis, Donald; Tsou, Marc; McGuire, Erin; Surran, Brooke; Miller, Crystal; Vu, Thuy-Anh (2011). "Abdominal Migraine: An Under-Diagnosed Cause of Recurrent Abdominal Pain in Children". Headache: The Journal of Head and Face Pain. 51 (5): 707–712. doi:10.1111/j.1526-4610.2011.01855.x. ISSN   0017-8748. PMID   21395574. S2CID   6813605.
  3. 1 2 3 4 Russell, George; Abu-Arafeh, Ishaq; Symon, David N.K. (2002). "Abdominal Migraine". Pediatric Drugs. 4 (1). Springer Science and Business Media LLC: 1–8. doi:10.2165/00128072-200204010-00001. ISSN   1174-5878. PMID   11817981. S2CID   12289726.
  4. ↑ Uc, Aliye; Hyman, Paul E.; Walker, Lynn S. (2006). "Functional Gastrointestinal Disorders in African American Children in Primary Care". Journal of Pediatric Gastroenterology & Nutrition. 42 (3). Wiley: 270–274. doi:10.1097/01.mpg.0000189371.29911.68. ISSN   0277-2116. PMC   3232040 . PMID   16540795.
  5. 1 2 3 4 5 6 Winner, Paul (2016). "Abdominal Migraine". Seminars in Pediatric Neurology. 23 (1). Elsevier BV: 11–13. doi:10.1016/j.spen.2015.09.001. ISSN   1071-9091. PMID   27017015.
  6. 1 2 Evans, Randolph W.; Whyte, Chad (May 30, 2013). "Cyclic Vomiting Syndrome and Abdominal Migraine in Adults and Children". Headache: The Journal of Head and Face Pain. 53 (6). Wiley: 984–993. doi:10.1111/head.12124. ISSN   0017-8748. PMID   23721241. S2CID   205159221.
  7. 1 2 Irwin, Samantha; Barmherzig, Rebecca; Gelfand, Amy (2017). "Recurrent Gastrointestinal Disturbance: Abdominal Migraine and Cyclic Vomiting Syndrome". Current Neurology and Neuroscience Reports. 17 (3). Springer Science and Business Media LLC: 21. doi:10.1007/s11910-017-0731-4. ISSN   1528-4042. PMID   28283964. S2CID   4458523.
  8. 1 2 Cervellin, Gianfranco; Lippi, Giuseppe (2015). "Abdominal migraine in the differential diagnosis of acute abdominal pain". The American Journal of Emergency Medicine. 33 (6). Elsevier BV: 864.e3–864.e5. doi:10.1016/j.ajem.2014.12.066. ISSN   0735-6757. PMID   25616589.
  9. ↑ Angus-Leppan, Heather (August 1, 2013). "Migraine: mimics, borderlands and chameleons". Practical Neurology. 13 (5). BMJ: 308–318. doi:10.1136/practneurol-2012-000502. ISSN   1474-7758. PMID   23906594. S2CID   33590756.
  10. ↑ Devanarayana, N. M.; Rajindrajith, S.; Perera, M. S.; Nishanthanie, S. W.; Karunanayake, A.; Benninga, M. A. (July 23, 2014). "Association Between Functional Gastrointestinal Diseases and Exposure to Abuse in Teenagers". Journal of Tropical Pediatrics. 60 (5). Oxford University Press (OUP): 386–392. doi:10.1093/tropej/fmu035. ISSN   0142-6338. PMID   25059210.
  11. ↑ Sutherland, Heidi G.; Griffiths, Lyn R. (2017). "Genetics of Migraine: Insights into the Molecular Basis of Migraine Disorders" (PDF). Headache: The Journal of Head and Face Pain. 57 (4): 537–569. doi:10.1111/head.13053. ISSN   0017-8748. PMID   28271496. S2CID   40801526.
  12. ↑ Giffin, N J; Benton, S; Goadsby, P J (2002). "Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation". Developmental Medicine & Child Neurology. 44 (7). Wiley: 490–493. doi: 10.1017/s0012162201002407 (inactive 2024-06-12). ISSN   0012-1622. PMID   12162387.{{cite journal}}: CS1 maint: DOI inactive as of June 2024 (link)
  13. ↑ DALE, RUSSELL C; GARDINER, ALICE; ANTONY, JAYNE; HOULDEN, HENRY (July 31, 2012). "Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine". Developmental Medicine & Child Neurology. 54 (10). Wiley: 958–960. doi: 10.1111/j.1469-8749.2012.04394.x . ISSN   0012-1622. PMID   22845787.
  14. ↑ Azmy, Demiana J.; Qualia, Cary M. (November 30, 2018). "Review of Abdominal Migraine in Children". Gastroenterology & Hepatology. 16 (12). Millenium Medical Publishing: 632–639. PMC   8132691 . PMID   34035698.
  15. ↑ Mortimer, M.J.; Good, P.A. (1990). "The VER as a Diagnostic Marker for Childhood Abdominal Migraine". Headache: The Journal of Head and Face Pain. 30 (10). Wiley: 642–645. doi:10.1111/j.1526-4610.1990.hed3010642.x. ISSN   0017-8748. PMID   2272813. S2CID   27579213.
  16. ↑ Good, Peter A. (1995). "Neurologic Investigations of Childhood Abdominal Migraine: A Combined Electrophysiologic Approach to Diagnosis". Journal of Pediatric Gastroenterology and Nutrition. 21. Wiley: S44–S48. doi:10.1097/00005176-199501001-00013. ISSN   0277-2116. PMID   8708868.
  17. ↑ Weydert, Joy A.; Ball, Thomas M.; Davis, Melinda F. (January 1, 2003). "Systematic Review of Treatments for Recurrent Abdominal Pain". Pediatrics. 111 (1). American Academy of Pediatrics (AAP): e1–e11. doi:10.1542/peds.111.1.e1. ISSN   0031-4005. PMID   12509588.
  18. ↑ Boles, R. G.; Zaki, E. A.; Lavenbarg, T.; Hejazi, R.; Foran, P.; Freeborn, J.; Trilokekar, S.; Mccallum, R. (August 5, 2009). "Are pediatric and adult-onset cyclic vomiting syndrome (CVS) biologically different conditions? Relationship of adult-onset CVS with the migraine and pediatric CVS-associated common mtDNA polymorphisms 16519T and 3010A". Neurogastroenterology & Motility. 21 (9). Wiley: 936–e72. doi:10.1111/j.1365-2982.2009.01305.x. ISSN   1350-1925. PMID   19368653. S2CID   43046971.
  19. 1 2 Napthali, Kate; Koloski, Natasha; Talley, Nicholas J (2016). "Abdominal migraine". Cephalalgia. 36 (10): 980–986. doi:10.1177/0333102415617748. ISSN   0333-1024. PMID   26582952. S2CID   23764515.
  20. ↑ Di Lorenzo, Carlo; Colletti, Richard B; Lehmann, Horald P; Boyle, John T; Gerson, William T; Hyams, Jeffrey S; Squires, Robert H; Walker, Lynn S; Kanda, Pamela T (2005). "Chronic Abdominal Pain In Children: A Technical Report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition". Journal of Pediatric Gastroenterology & Nutrition. 40 (3). Wiley: 249–261. doi:10.1097/01.mpg.0000154661.39488.ac. ISSN   0277-2116. PMID   15735476.
  21. ↑ McFerron, Brian A.; Waseem, Shamaila (November 1, 2012). "Chronic Recurrent Abdominal Pain". Pediatrics in Review. 33 (11). American Academy of Pediatrics (AAP): 509–517. doi:10.1542/pir.33.11.509. ISSN   0191-9601. PMID   23118316.
  22. ↑ "Rome IV Criteria". Rome Foundation. March 6, 2023. Retrieved December 31, 2023.
  23. 1 2 3 4 Angus-Leppan, Heather; Saatci, Defne; Sutcliffe, Alastair; Guiloff, Roberto J. (19 February 2018). "Abdominal migraine". British Medical Journal . 360: k179. doi:10.1136/bmj.k179. ISSN   0959-8138. PMID   29459383. S2CID   5256538.
  24. ↑ Lundberg, P. O. (1975). "Abdominal Migraine-Diagnosis and Therapy". Headache: The Journal of Head and Face Pain. 15 (2). Wiley: 122–125. doi:10.1111/j.1526-4610.1975.hed1502122.x. ISSN   0017-8748. PMID   1150428. S2CID   23179583.
  25. 1 2 Worawattanakul, Mingmuang; Rhoads, J. Marc; Lichtman, Steven N.; Ulshen, Martin H. (1999). "Abdominal Migraine: Prophylactic Treatment and Follow-up". Journal of Pediatric Gastroenterology & Nutrition. 28 (1). Wiley: 37–40. doi:10.1097/00005176-199901000-00010. ISSN   0277-2116. PMID   9890466.
  26. ↑ Catala-Beauchamp, Aixa I.; Gleason, Robyn P. (2012). "Abdominal Migraine in Children: Is It All in Their Heads?". The Journal for Nurse Practitioners. 8 (1). Elsevier BV: 19–26. doi:10.1016/j.nurpra.2011.06.007. ISSN   1555-4155.
  27. ↑ Blume, Heidi K.; Brockman, Libby N.; Breuner, Cora C. (July 13, 2012). "Biofeedback Therapy for Pediatric Headache: Factors Associated With Response". Headache: The Journal of Head and Face Pain. 52 (9). Wiley: 1377–1386. doi:10.1111/j.1526-4610.2012.02215.x. ISSN   0017-8748. PMID   22804229. S2CID   23605499.
  28. ↑ Aydinlar, Elif Ilgaz; Dikmen, Pinar Yalinay; Tiftikci, Arzu; Saruc, Murat; Aksu, Muge; Gunsoy, Hulya G.; Tozun, Nurdan (December 6, 2012). "<scp>IgG</scp>-Based Elimination Diet in Migraine Plus Irritable Bowel Syndrome". Headache: The Journal of Head and Face Pain. 53 (3). Wiley: 514–525. doi:10.1111/j.1526-4610.2012.02296.x. ISSN   0017-8748. PMID   23216231. S2CID   34736265.
  29. ↑ Gelfand, Amy A. (2013). "Migraine and childhood periodic syndromes in children and adolescents". Current Opinion in Neurology. 26 (3). Ovid Technologies (Wolters Kluwer Health): 262–268. doi:10.1097/wco.0b013e32836085c7. ISSN   1350-7540. PMID   23549418.
  30. ↑ Symon, D N; Russell, G (January 1, 1995). "Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine". Archives of Disease in Childhood. 72 (1). BMJ: 48–50. doi:10.1136/adc.72.1.48. ISSN   0003-9888. PMC   1510964 . PMID   7717738.
  31. ↑ Kothare, Sanjeev V. (2005). "Efficacy of flunarizine in the prophylaxis of cyclical vomiting syndrome and abdominal migraine". European Journal of Paediatric Neurology. 9 (1). Elsevier BV: 23–26. doi:10.1016/j.ejpn.2004.11.002. ISSN   1090-3798. PMID   15701563.
  32. ↑ Lewis, Donald W; Yonker, Marcy; Winner, Paul; Sowell, Michael (2005). "The Treatment of Pediatric Migraine". Pediatric Annals. 34 (6). SLACK, Inc.: 448–460. doi:10.3928/0090-4481-20050601-10. ISSN   0090-4481. PMID   16018227.
  33. ↑ Kakisaka, Yosuke; Wakusawa, Keisuke; Haginoya, Kazuhiro; Saito, Akiko; Uematsu, Mitsugu; Yokoyama, Hiroyuki; Sato, Tetsuo; Tsuchiya, Shigeru (June 9, 2009). "Efficacy of Sumatriptan in Two Pediatric Cases With Abdominal Pain-Related Functional Gastrointestinal Disorders: Does the Mechanism Overlap That of Migraine?". Journal of Child Neurology. 25 (2). SAGE Publications: 234–237. doi:10.1177/0883073809336875. ISSN   0883-0738. PMID   19509407. S2CID   41114159.
  34. ↑ Tan, Violeta; Revelo Sahami, Alcira; Peebles, Rebecka; Shaw, Richard J. (2006). "Abdominal Migraine and Treatment With Intravenous Valproic Acid". Psychosomatics. 47 (4). Elsevier BV: 353–355. doi:10.1176/appi.psy.47.4.353. ISSN   0033-3182. PMID   16844896.
  35. ↑ Raina, Madiha; Chelimsky, Gisela; Chelimsky, Thomas (July 1, 2013). "Intravenous Dihydroergotamine Therapy for Pediatric Abdominal Migraines". Clinical Pediatrics. 52 (10). SAGE Publications: 918–921. doi:10.1177/0009922813492879. ISSN   0009-9228. PMID   23820001. S2CID   206405642.
  36. 1 2 Catto-Smith, AG; Ranuh, R (Nov 2003). "Abdominal migraine and cyclical vomiting". Seminars in Pediatric Surgery. 12 (4): 254–8. doi:10.1053/j.sempedsurg.2003.08.006. PMID   14655164.
  37. ↑ Napthali, Kate; Koloski, Natasha; Talley, Nicholas J (2016-07-19). "Abdominal migraine". Cephalalgia. 36 (10): 980–986. doi:10.1177/0333102415617748. ISSN   0333-1024. PMID   26582952. S2CID   23764515.
  38. ↑ "Headache: Hope through research". NINDS. April 2016.
  39. ↑ Evans RW, Whyte C. Cyclic vomiting syndrome and abdominal migraine in adults and children. Headache. 2013;53:984–993
  40. ↑ Monteferrante, Nikolas, Ho, Jacquelyn, Wilhelmi, Brian, MD, JD, Uribe, Juan. Prevention of Perioperative Abdominal Migraine in a Patient Undergoing Spinal Fusion: A Case Report. A A Pract. 2021;15(6):e01484. doi:10.1213/XAA.0000000000001484.
  41. ↑ Tepper, Stewart J.; Tepper, Deborah E., eds. (2011-08-22). The Cleveland Clinic manual of headache therapy. New York: Springer. p. 96. ISBN   9781461401780.
  42. ↑ Davidoff, Robert A. (2002). Migraine : manifestations, pathogenesis, and management (2nd ed.). Oxford [u.a.]: Oxford Univ. Press. p. 81. ISBN   9780195137057.
  43. ↑ Mani, Jyoti; Madani, Shailender (2018-04-24). "Pediatric abdominal migraine: current perspectives on a lesser known entity". Pediatric Health, Medicine and Therapeutics. 9: 47–58. doi: 10.2147/PHMT.S127210 . ISSN   1179-9927. PMC   5923275 . PMID   29733088.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.